Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method

por Arildsen, Nicolai Skovbjerg, Martin de la Fuente, Laura, Måsbäck, Anna, Malander, Susanne, Forslund, Ola, Kannisto, Päivi, Hedenfalk, Ingrid
Publicado 2019

Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response

por Martín de la Fuente, Laura, Malander, Susanne, Hartman, Linda, Jönsson, Jenny-Maria, Ebbesson, Anna, Nilbert, Mef, Måsbäck, Anna, Hedenfalk, Ingrid
Publicado 2018

PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma

por Martin de la Fuente, Laura, Westbom-Fremer, Sofia, Arildsen, Nicolai Skovbjerg, Hartman, Linda, Malander, Susanne, Kannisto, Päivi, Måsbäck, Anna, Hedenfalk, Ingrid
Publicado 2020

SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery

por Bååth, Maria, Westbom-Fremer, Sofia, Martin de la Fuente, Laura, Ebbesson, Anna, Davis, Juliette, Malander, Susanne, Måsbäck, Anna, Kannisto, Päivi, Hedenfalk, Ingrid
Publicado 2020

MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer

por Bååth, Maria, Jönsson, Jenny-Maria, Westbom Fremer, Sofia, Martín de la Fuente, Laura, Tran, Lena, Malander, Susanne, Kannisto, Päivi, Måsbäck, Anna, Honeth, Gabriella, Hedenfalk, Ingrid
Publicado 2021